2024 annual financial data
Zhengye Biotechnology Holding 2024 Operating cash flow growth
Direct answer
Operating cash flow growth was -14.81%.
Operating income was 17,172,000 CNY and net income was 11,311,000 CNY.
Operating cash flow was 41,046,000 CNY.
Get free Zhengye Biotechnology Holding email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 186,356,000 CNY
- Operating income
- 17,172,000 CNY
- Net income
- 11,311,000 CNY
- Operating cash flow
- 41,046,000 CNY